376 related articles for article (PubMed ID: 29436794)
1. The Follow-Up Role of the Vestibular Evoked Myogenic Potential Test in Meniere's Disease.
Yazdani N; Nejadian F; Rezazadeh N; Hoseinabadi R; Karimi E; Gharibi R; Dabiri S
Acta Med Iran; 2018 Jan; 56(1):43-48. PubMed ID: 29436794
[TBL] [Abstract][Full Text] [Related]
2. Differences in responsiveness of intratympanic steroid injection for intractable vertigo in Meniere's disease.
Okuda H; Aoki M; Ogawa B; Shibata H; Ueda N; Ohashi T; Hayashi H; Nishihori T; Kuze B; Ogawa T
Am J Otolaryngol; 2021; 42(6):103141. PubMed ID: 34171697
[TBL] [Abstract][Full Text] [Related]
3. Altered frequency dynamics of cervical and ocular vestibular evoked myogenic potentials in patients with Ménière's disease.
Sandhu JS; Low R; Rea PA; Saunders NC
Otol Neurotol; 2012 Apr; 33(3):444-9. PubMed ID: 22334161
[TBL] [Abstract][Full Text] [Related]
4. Refractory episodic vertigo: role of intratympanic gentamicin and vestibular evoked myogenic potentials.
Celis-Aguilar E; Hinojosa-González R; Vales-Hidalgo O; Coutinho-Toledo H
Braz J Otorhinolaryngol; 2016; 82(6):668-673. PubMed ID: 27068887
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Saccular Function With Vestibular Evoked Myogenic Potential Test in Meniere's Disease.
Dabiri S; Yazdani N; Esfahani M; Tari N; Adil S; Mahvi Z; Rezazadeh N
Acta Med Iran; 2017 Feb; 55(2):123-127. PubMed ID: 28282709
[TBL] [Abstract][Full Text] [Related]
6. The role of caloric testing and the vestibular evoked myogenic potential in the efficacy of intratympanic dexamethasone injection in 201 patients with unilateral Meniere's disease.
Yu YF; Zhang YM; Shi C; Pan C
Clin Otolaryngol; 2020 Jul; 45(4):634-642. PubMed ID: 32304344
[No Abstract] [Full Text] [Related]
7. Intratympanic Dexamethasone in the Treatment of Ménière's Disease: A Comparison of Two Techniques.
Beyea JA; Instrum RS; Agrawal SK; Parnes LS
Otol Neurotol; 2017 Jul; 38(6):e173-e178. PubMed ID: 28437363
[TBL] [Abstract][Full Text] [Related]
8. Intratympanic gentamicin injection for refractory ménière's disease (MD) has potential effect in preventing contralateral MD occurrence.
Wu Y; Zhou Y; Yu J; Song Z; Dai C; Wang J
Acta Otolaryngol; 2021 Jul; 141(7):657-662. PubMed ID: 33950779
[TBL] [Abstract][Full Text] [Related]
9. Vestibular evoked myogenic potentials in benign paroxysmal positional vertigo and Meniere's disease.
Akkuzu G; Akkuzu B; Ozluoglu LN
Eur Arch Otorhinolaryngol; 2006 Jun; 263(6):510-7. PubMed ID: 16482459
[TBL] [Abstract][Full Text] [Related]
10. Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.
Lee SY; Kim YS; Jeong B; Carandang M; Koo JW; Oh SH; Lee JH
Am J Otolaryngol; 2021; 42(6):103086. PubMed ID: 34098455
[TBL] [Abstract][Full Text] [Related]
11. Vestibular evoked myogenic potentials show altered tuning in patients with Ménière's disease.
Rauch SD; Zhou G; Kujawa SG; Guinan JJ; Herrmann BS
Otol Neurotol; 2004 May; 25(3):333-8. PubMed ID: 15129114
[TBL] [Abstract][Full Text] [Related]
12. Response Over Time of Vertigo Spells to Intratympanic Dexamethasone Treatment in Meniere's Disease Patients.
Atrache Al Attrache N; Krstulovic C; Pérez Guillen V; Morera Pérez C; Pérez Garrigues H
J Int Adv Otol; 2016 Apr; 12(1):92-7. PubMed ID: 27340991
[TBL] [Abstract][Full Text] [Related]
13. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
Minor LB
Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
[TBL] [Abstract][Full Text] [Related]
14. Transitory effect on endolymphatic hydrops of the intratympanic steroids for Ménière's disease.
Martin-Sanz E; Esteban-Sanchez J; Rodrigañez-Riesco L; Sanz-Fernández R
Laryngoscope; 2015 May; 125(5):1183-8. PubMed ID: 25429741
[TBL] [Abstract][Full Text] [Related]
15. Control of vertigo in Ménière's disease by intratympanic dexamethasone.
Weckel A; Marx M; Esteve-Fraysse MJ
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Feb; 135(1):7-10. PubMed ID: 28760618
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of vestibular evoked myogenic potential, caloric test and cochlear electrogram in the diagnosis of Meniere's disease].
Xu M; Chen ZC; Wei XY; Zhang YZ; Yang FY; Zhang C; Chen FY; Hu J; Cheng Y; Zhang Q
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Aug; 33(8):704-708. PubMed ID: 31446722
[No Abstract] [Full Text] [Related]
17. Assessment of endolymphatic hydrops and otolith function in patients with Ménière's disease.
Okumura T; Imai T; Takimoto Y; Takeda N; Kitahara T; Uno A; Kamakura T; Osaki Y; Watanabe Y; Inohara H
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1413-1421. PubMed ID: 27942898
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of tone burst vestibular evoked myogenic potentials at threshold in acute and stable Ménière's disease.
Osei-Lah V; Ceranic B; Luxon LM
J Laryngol Otol; 2008 May; 122(5):452-7. PubMed ID: 17605832
[TBL] [Abstract][Full Text] [Related]
19. Visualization of endolymphatic hydrops and correlation with audio-vestibular functional testing in patients with definite Meniere's disease.
Seo YJ; Kim J; Choi JY; Lee WS
Auris Nasus Larynx; 2013 Apr; 40(2):167-72. PubMed ID: 22867525
[TBL] [Abstract][Full Text] [Related]
20. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
Öztürk K; Ata N
Am J Otolaryngol; 2019; 40(5):711-714. PubMed ID: 31262549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
